Radiation Oncology

Outstanding radiation oncology care is crucial for many of our patients with cancer. Montefiore Medical Center's renowned Department of Radiation Oncology sets the standard by developing and incorporating the newest technologies and methods available to combat the progress of the disease.

We have long been at the forefront of translational research — "translating" our findings in the laboratory into practical applications to better fight cancer. As a result, we can offer superior treatment and care for our patients with cancer.

Putting the Patient First

At Montefiore, our approach is patient-focused. While the majority of cancer patients are candidates for some form of radiation treatment — either alone or in conjunction with chemotherapy or surgery — we understand that each patient's situation is unique. Our internationally recognized, multidisciplinary team works with each patient, applying decades of expertise to determine the right course of therapy.

It is our priority to ensure that our patients and their families have a full understanding of radiation therapy options and courses of treatment. Our skilled and compassionate staff provides our patients with the information and support they need before, during and after treatment.

We also strive to make treatment as convenient as possible, offering two locations for radiation therapy throughout Montefiore's service area.

On the Leading Edge of Technology

Montefiore stays on the leading edge of technology through our involvement in translational research and clinical trials. We are constantly making strides in maximizing the effectiveness of radiation therapy while protecting healthy cells and minimizing discomfort and side effects.

Montefiore's history of innovation in drug and radiation therapy includes our use of Intensity Modulated Radiation Therapy (IMRT) for some of our cancer patients. This advanced technique focuses hundreds of tiny micro-beams of different intensities of radiation directly at the tumor. IMRT allows us to combat tumors more specifically and intelligently than ever before. The effect is far less traumatic to our patients, with minimal damage to the body's healthy tissue.